Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
US Stock MarketDetailed Quotes
CF CF Industries Holdings
- 79.590
- +1.440+1.84%
Close Apr 1 16:00 ET
- 80.000
- +0.410+0.52%
Post 19:56 ET
13.25BMarket Cap11.81P/E (TTM)
79.640High77.230Low1.75MVolume78.450Open78.150Pre Close138.20MTurnover1.06%Turnover Ratio11.81P/E (Static)166.47MShares97.64752wk High2.66P/B13.12BFloat Cap67.88052wk Low2.00Dividend TTM164.80MShs Float113.075Historical High2.51%Div YieldTTM3.08%Amplitude1.567Historical Low79.141Avg Price1Lot Size
CF Industries Holdings Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.48%5.94B | -2.99%1.52B | 7.62%1.37B | -11.44%1.57B | -26.94%1.47B | -40.72%6.63B | -39.76%1.57B | -45.15%1.27B | -47.62%1.78B | -29.85%2.01B |
| Operating revenue | -10.48%5.94B | -2.99%1.52B | 7.62%1.37B | -11.44%1.57B | -26.94%1.47B | -40.72%6.63B | -39.76%1.57B | -45.15%1.27B | -47.62%1.78B | -29.85%2.01B |
| Cost of revenue | -5.04%3.88B | -6.54%1B | 3.35%926M | -8.03%893M | -7.66%1.06B | -23.27%4.09B | -20.86%1.07B | -36.23%896M | -30.54%971M | -1.79%1.15B |
| Gross profit | -19.21%2.06B | 4.59%524M | 17.77%444M | -15.55%679M | -52.61%409M | -56.58%2.55B | -60.11%501M | -58.84%377M | -59.62%804M | -49.18%863M |
| Operating expense | 17.75%345M | 22.22%121M | 1.23%82M | -50.00%37M | 169.23%105M | 1.03%293M | 83.33%99M | -10.99%81M | -6.33%74M | -40.91%39M |
| Selling and administrative expenses | 10.73%320M | 2.63%78M | 14.71%78M | 7.04%76M | 18.92%88M | -0.34%289M | -12.64%76M | 3.03%68M | -2.74%71M | 15.63%74M |
| -General and administrative expense | 10.73%320M | ---- | ---- | ---- | ---- | -0.34%289M | ---- | ---- | ---- | ---- |
| Other operating expenses | 525.00%25M | 86.96%43M | -69.23%4M | -1,400.00%-39M | 148.57%17M | --4M | --23M | -48.00%13M | -50.00%3M | -1,850.00%-35M |
| Operating profit | -24.02%1.71B | 0.25%403M | 22.30%362M | -12.05%642M | -63.11%304M | -59.58%2.25B | -66.56%402M | -64.12%296M | -61.82%730M | -49.51%824M |
| Net non-operating interest income expense | -75.00%2M | -275.00%-14M | 433.33%32M | -325.00%-9M | 30.00%-7M | 102.87%8M | -76.47%8M | 117.65%6M | 105.41%4M | 95.12%-10M |
| Non-operating interest income | -6.25%150M | -48.89%23M | 53.33%69M | -30.00%28M | 0.00%30M | 146.15%160M | 400.00%45M | 275.00%45M | 400.00%40M | -16.67%30M |
| Non-operating interest expense | -3.47%139M | 0.00%35M | -8.11%34M | 2.94%35M | -7.89%35M | -57.14%144M | 229.63%35M | -15.91%37M | -57.50%34M | -84.10%38M |
| Total other finance cost | 12.50%9M | 0.00%2M | 50.00%3M | 0.00%2M | 0.00%2M | 0.00%8M | 0.00%2M | 0.00%2M | 0.00%2M | 0.00%2M |
| Other net income (expense) | 508.33%49M | 69.23%44M | 112.24%6M | -166.67%-4M | -40.00%3M | 93.91%-12M | 44.44%26M | 50.00%-49M | 104.23%6M | -80.00%5M |
| Earnings from equity interest | 150.00%4M | -25.00%3M | 105.56%2M | -142.86%-3M | -88.24%2M | -108.51%-8M | -80.00%4M | -280.00%-36M | -75.00%7M | -34.62%17M |
| Special income (charges) | 321.43%31M | 75.00%35M | --0 | 66.67%-1M | 80.00%-3M | 94.66%-14M | 566.67%20M | 83.16%-16M | 98.24%-3M | ---15M |
| -Less：Restructuring and merger&acquisition | -91.84%4M | --0 | --0 | -66.67%1M | -80.00%3M | 157.89%49M | 1,400.00%15M | 100.00%16M | -70.00%3M | --15M |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | 0.00%35M | ---- | ---- | ---- | ---- | 775.00%35M | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 40.00%14M | 200.00%6M | 33.33%4M | ---- | 33.33%4M | 166.67%10M | -77.78%2M | 113.04%3M | --2M | 400.00%3M |
| Income before tax | -21.62%1.76B | -0.69%433M | 58.10%400M | -15.00%629M | -63.37%300M | -55.88%2.25B | -65.23%436M | -63.49%253M | -56.37%740M | -43.60%819M |
| Income tax | -30.49%285M | -51.19%41M | 156.52%59M | -8.21%123M | -63.31%62M | -64.59%410M | -65.71%84M | -85.16%23M | -62.46%134M | -57.86%169M |
| Net income | -19.64%1.48B | 11.36%392M | 48.26%341M | -16.50%506M | -63.38%238M | -53.31%1.84B | -65.11%352M | -57.25%230M | -54.74%606M | -38.15%650M |
| Net income continuous Operations | -19.64%1.48B | 11.36%392M | 48.26%341M | -16.50%506M | -63.38%238M | -53.31%1.84B | -65.11%352M | -57.25%230M | -54.74%606M | -38.15%650M |
| Minority interest income | -17.25%259M | -17.95%64M | -1.52%65M | 8.86%86M | -51.11%44M | -47.04%313M | -47.65%78M | -34.00%66M | -54.60%79M | -46.43%90M |
| Net income attributable to the parent company | -20.13%1.22B | 19.71%328M | 68.29%276M | -20.30%420M | -65.36%194M | -54.42%1.53B | -68.14%274M | -62.56%164M | -54.76%527M | -36.58%560M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -20.13%1.22B | 19.71%328M | 68.29%276M | -20.30%420M | -65.36%194M | -54.42%1.53B | -68.14%274M | -62.56%164M | -54.76%527M | -36.58%560M |
| Basic earnings per share | -14.45%6.75 | 31.25%1.89 | 82.35%1.55 | -15.13%2.3 | -63.99%1.03 | -52.04%7.89 | -67.05%1.44 | -61.19%0.85 | -51.52%2.71 | -32.39%2.86 |
| Diluted earnings per share | -14.36%6.74 | 31.25%1.89 | 82.35%1.55 | -14.81%2.3 | -63.86%1.03 | -51.95%7.87 | -66.90%1.44 | -61.01%0.85 | -51.61%2.7 | -32.30%2.85 |
| Dividend per share | 25.00%2 | 25.00%0.5 | 25.00%0.5 | 25.00%0.5 | 25.00%0.5 | 6.67%1.6 | 0.00%0.4 | 0.00%0.4 | 0.00%0.4 | 33.33%0.4 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now